These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 36377442)

  • 1. [Analyze the application rules and effects of "Four Elements, One Peptide, and Two Transplantations" based on bundle treatment in coronavirus disease 2019].
    Yan Y; Lyu C; Davgadorj C; Huang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Sep; 34(9):909-914. PubMed ID: 36377442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analyze the clinical characteristics of mild and severe SARS-CoV-2 infected patients based on the local Omicron variant epidemic].
    Yan Y; Lyu C; Davgadorj C; Wang X; Sha M
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Jan; 35(1):32-36. PubMed ID: 36880235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the effects of immunotherapy and mesenchymal stem cells transplantation in the treatment of critically ill coronavirus disease 2019 patients].
    Yan Y; Jiang X; Ding D; Huang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):139-144. PubMed ID: 33729129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical efficacy and safety of different antiviral regimens in patients with coronavirus disease 2019].
    Gao X; Ma C; Ma Y; Wang X; Wei J; Feng T; Zhao G; Xu L; Zhou W; Zheng X; Zhao Q; Cao X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1423-1427. PubMed ID: 33541491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between the early dynamic changes of lymphocyte and severity of disease in coronavirus disease 2019 patients].
    Zhou J; Zhou Y; Cai J; Lin S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Aug; 33(8):922-926. PubMed ID: 34590557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of age on the clinical and immune characteristics of critically ill patients with COVID-19: A preliminary report.
    Hu C; Li J; Xing X; Gao J; Zhao S; Xing L
    PLoS One; 2021; 16(3):e0248675. PubMed ID: 33735325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical characteristics and CT imaging features of patients with different clinical types of coronavirus disease 2019].
    Liu C; Deng X; Pan Y; Ling Z; Zhang G; Wei G; Peng P; He X; Zhang F
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):548-553. PubMed ID: 32576345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retrospective observation and analysis of autoimmune-related indicators in 317 patients with acute Omicron variant infection].
    Guo X; Luo X; Wu B; Wang W; Wang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jun; 34(6):581-585. PubMed ID: 35924511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of clinical value of Xuebijing combined with human immunoglobulin in severe and critically ill patients with coronavirus disease 2019].
    Chen L; Zhang A; Li Q; Cui Y; Yuan G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Apr; 33(4):399-404. PubMed ID: 34053480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu.
    Zheng Y; Xu H; Yang M; Zeng Y; Chen H; Liu R; Li Q; Zhang N; Wang D
    J Clin Virol; 2020 Jun; 127():104366. PubMed ID: 32302954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis of severe/critical 2019 novel coronavirus Omicron variant infection combined with atrial fibrillation].
    Zhao Z; Wang S; Zhu L; Huan Q; Tian B; Hao S; Ning Z; Song X; Li X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Sep; 34(9):900-904. PubMed ID: 36377440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
    Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research on Influencing Factors and Classification of Patients With Mild and Severe COVID-19 Symptoms.
    Chen X; Zheng L; Ye S; Xu M; Li Y; Lv K; Zhu H; Jie Y; Chen YQ
    Front Cell Infect Microbiol; 2021; 11():670823. PubMed ID: 34490135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Coronavirus disease 2019 in Northeastern Sichuan: clinical characteristics and treatment analysis of 59 cases].
    Li B; Zhang S; Luo S; Liu C; Jia W; Jiang H; Dai Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Mar; 33(3):352-356. PubMed ID: 33834980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the clinical application value of peripheral blood T lymphocyte subset in patients with asymptomatic omicron infection.
    Li T; Xu J; Gao Y; Wang X; Xu Y
    Eur J Med Res; 2023 Jul; 28(1):223. PubMed ID: 37408049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Clinical and Immunological Characteristics With Disease Severity and Outcomes in 211 Patients With COVID-19 in Wuhan, China.
    Wang M; Fan Y; Chai Y; Cheng W; Wang K; Cao J; Hu X
    Front Cell Infect Microbiol; 2021; 11():667487. PubMed ID: 34123873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.